These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7735921)

  • 1. Restriction isotyping of apolipoprotein E R145C in type III hyperlipoproteinemia.
    Hsia SH; Connelly PW; Hegele RA
    J Investig Med; 1995 Apr; 43(2):187-94. PubMed ID: 7735921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of a new apolipoprotein-E mutation in type III hyperlipidemia using deoxyribonucleic acid restriction isotyping.
    Walden CC; Huff MW; Leiter LA; Connelly PW; Hegele RA
    J Clin Endocrinol Metab; 1994 Mar; 78(3):699-704. PubMed ID: 7907341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe type III hyperlipoproteinemia associated with unusual apolipoprotein E1 phenotype and epsilon 1/'null' genotype.
    Feussner G; Funke H; Weng W; Assmann G; Lackner KJ; Ziegler R
    Eur J Clin Invest; 1992 Sep; 22(9):599-608. PubMed ID: 1360898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of variant apolipoprotein E by isoelectric focusing and restriction isotyping in a patient with type III hyperlipoproteinemia.
    Nassar BA; McPherson R; Lamothe EM; al-Sultan AI; Zhang ZJ; Rosenblatt DS
    Clin Chem; 1991 Jul; 37(7):1308. PubMed ID: 1677318
    [No Abstract]   [Full Text] [Related]  

  • 5. Discovery and consequences of apolipoprotein-epsilon(3Groningen): a G-insertion in codon 95/96 that is predicted to cause a premature stop codon.
    Dijck-Brouwer DA; van Doormaal JJ; Kema IP; Brugman AM; Kingma AW; Muskiet FA
    Ann Clin Biochem; 2005 Jul; 42(Pt 4):264-8. PubMed ID: 15989726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type III hyperlipoproteinemia associated with apolipoprotein E phenotype E3/3. Structure and genetics of an apolipoprotein E3 variant.
    Rall SC; Newhouse YM; Clarke HR; Weisgraber KH; McCarthy BJ; Mahley RW; Bersot TP
    J Clin Invest; 1989 Apr; 83(4):1095-101. PubMed ID: 2539388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E-4Philadelphia (Glu13----Lys,Arg145----Cys). Homozygosity for two rare point mutations in the apolipoprotein E gene combined with severe type III hyperlipoproteinemia.
    Lohse P; Mann WA; Stein EA; Brewer HB
    J Biol Chem; 1991 Jun; 266(16):10479-84. PubMed ID: 1674745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E2-Christchurch (136 Arg----Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia.
    Wardell MR; Brennan SO; Janus ED; Fraser R; Carrell RW
    J Clin Invest; 1987 Aug; 80(2):483-90. PubMed ID: 3038959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type III hyperlipoproteinemia with xanthomas and multiple myeloma.
    Burnside NJ; Alberta L; Robinson-Bostom L; Bostom A
    J Am Acad Dermatol; 2005 Nov; 53(5 Suppl 1):S281-4. PubMed ID: 16227109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E2 (Arg-136-->Cys), a variant of apolipoprotein E associated with late-onset dominance of type III hyperlipoproteinaemia.
    Feussner G; Albanese M; Mann WA; Valencia A; Schuster H
    Eur J Clin Invest; 1996 Jan; 26(1):13-23. PubMed ID: 8682150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unusual xanthomas in a young patient with heterozygous familial hypercholesterolemia and type III hyperlipoproteinemia.
    Feussner G; Dobmeyer J; Nissen H; Hansen TS
    Am J Med Genet; 1996 Oct; 65(2):149-54. PubMed ID: 8911609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of an apolipoprotein(e) variant associated with type III hyperlipoproteinaemia in an indigenous Australian.
    Tate JR; Hoffmann MM; Lovelock PK; Kesting JB; Shaw JT
    Ann Clin Biochem; 2001 Jan; 38(Pt 1):46-53. PubMed ID: 11270841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification, molecular characterization, and cellular studies of an apolipoprotein E mutant (E1) in three unrelated families with hyperlipidemia.
    Miller DB; Hegele RA; Wolfe BM; Huff MW
    J Clin Endocrinol Metab; 1995 Mar; 80(3):807-13. PubMed ID: 7883834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis of type III hyperlipoproteinemia in Germany.
    Feussner G; Feussner V; Hoffmann MM; Lohrmann J; Wieland H; März W
    Hum Mutat; 1998; 11(6):417-23. PubMed ID: 9603433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Apolipoprotein E phenotyping--useful in the study of hyperlipoproteinemia type III].
    Hagve TA; Furuset T; Christophersen B; Ose L
    Tidsskr Nor Laegeforen; 1993 Mar; 113(7):853-6. PubMed ID: 8480294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathology of the human apolipoprotein E gene].
    Iron A; Richard P; Beucler I; Thomas G; Pascual de Zulueta M; Bereziat G; Cassaigne A; de Gennes JL
    Bull Acad Natl Med; 1994 Mar; 178(3):415-26. PubMed ID: 8076181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compound heterozygotes for a novel mutation, apo E1 Nagoya (Arg142Ser) and Apo E2 (Arg158Cys), with severe type III hyperlipoproteinemia and familial hypercholesterolemia.
    Sakuma N; Hibino T; Saeki T; Nagata T; Sato T; Okuda N; Matsunaga A; Sasaki J
    J Atheroscler Thromb; 2014; 21(9):983-8. PubMed ID: 24953047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotyping of apolipoprotein E by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Srinivasan JR; Kachman MT; Killeen AA; Akel N; Siemieniak D; Lubman DM
    Rapid Commun Mass Spectrom; 1998; 12(16):1045-50. PubMed ID: 9737011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multiple molecular-genetic defects in a woman with mixed hyperlipoproteinemia and early ischemic heart disease].
    Malyshev PP; Stambol'skiĭ DV; Meshkov AN; Davydova IuV; Kukharchuk VV
    Ter Arkh; 2003; 75(10):71-4. PubMed ID: 14669611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel 18-amino acid deletion in apolipoprotein E associated with lipoprotein glomerulopathy.
    Ando M; Sasaki J; Hua H; Matsunaga A; Uchida K; Jou K; Oikawa S; Saito T; Nihei H
    Kidney Int; 1999 Oct; 56(4):1317-23. PubMed ID: 10504484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.